The Life and Times of Biomet

Fiscal Years 1978 – 2012

I U Kokomo

Kokomo, Indiana

February 12,

2013

1977

Incorporated in November

8 Team Members

Early Financing

$725,000 Capital

$500,000 SBA Guaranteed Loan

$100,000 Revolving Line

$125,000 Equity

1977

Began Developing Major

Technological Advances

Titanium Alloy

Reconstructive Products

Direct Compression Molded

Polyethylene

Titanium Plasma Spray

Porous Coating

1978

Biomet Moved into Initial Facility

$17,000 Net Sales

$63,000 Net Loss

Recipient of Biomet’s 1st Hip Implant:Dane Miller’s Maternal Grandmother,

Grace Shumaker

1978 - 1st Color Print Advertisement

“The Newest Manufacturer of Orthopedic Implants

is Working Nearly Around the Clock…

That’s Why the Lights Are Still On”

1979

The Total Cruciate Condylar Knee

Predecessor to the AGC Total Knee

Incorporated Biomet’s 1st Compression

Molded Tibial Component

1979

Jerry & Kenneth Miller

Provided Biomet with Early

Equity Financing

Served on Biomet’s Board

of Directors for many years

1980

$1.1 Million Net Sales

Ground-Breaking for Current Site

Financed by Sale of Economic

Development Revenue Bonds

1981

$1.25 Million Raised in Subordinated

Debenture Offering

Facility Completion

23,000 Sq. Ft.

3 Independent Locations Vacated (53 Team Members)

Produced Biomet’s 1st Annual Report

Theme: “Not Just Another Year”

1982

$3.5 Million Net Sales

$1.25 Million Raised through Initial Public Offering

1983

AGC Total Knee

1st System to Offer Complete

Component Interchangeability

Top Performer with Excellent

Clinical Results

March Stock Split: 2 for 1

July Stock Split: 2 for 1

$11.9 Million Raised in

Secondary Public Offering

1984

Introduction of Titanium Plasma

Spray Porous Coating

Acquisition of Orthopedic

Equipment Company

Expanded Biomet’s Worldwide

Market Presence

$10.6 Million Net Sales

1984

Indiana Small Business

Person of the Year

Meeting with President Reagan

1985

New Products

Bi-Metric Hip for cementless

or cemented implantation

AGC Calibrated Distractor

Redi-Drape

1986

Stock Split: 2 for 1

$44.1 Million Net Sales

$24.7 Million Raised in

Secondary Public Offering

1986

Groundbreaking for 3rd Building

Addition of 66,000 Sq. Ft.

$500,000 SBA Loan Retired Early

Estimated $9 Million Combined

Corporate & Personal Tax Revenues

Collected as Result of Funding

1987

Biomet Gaining National

Media Exposure as “Hot

Growth Company”

1988

Acquisition of EBI

Leader in Electrical Stimulation &

External Fixation Markets

New plant in Swindon,

England Replaced

Leased Facilities

$97.6 Million Net Sales

Stock Split: 3 for 2

1989

Introduction of Bi-Angular

Total Shoulder System

Stock Split: 3 for 2

1,000 Team Members

Indiana Business Publication Names

Miller “Entrepreneur of the Year”

for High Technology Sector

1990

$162.4 Million Net Sales

EBI Introduces SpF-T Line of Spinal

Fusion Stimulators

1991

President George Bush presented Small Business

Administration National Entrepreneurial Success

Award to Miller & Noblitt

Biomet Led Forbes’ Honor Role of Small

Publicly Traded Companies

1991

January Stock Split: 2 for 1

3-Story 43,000 Sq. Ft. Facility Expansion

11,000 Sq. Ft. Building Constructed in

Warsaw for Resorbable Material Technologies

December Stock Split: 2 for 1

1992

$274.8 Million Net Sales

Acquisition of Lorenz Surgical in

Jacksonville

Market Leader in Craniomaxillofacial

Fixation Products

1993

Swedish Knee Study Reported AGC Knee

Had Lowest Revision Rate of Knees in Study

Introduction of Maxim Total Knee System

1,760 Team Members

Biomet 3rd on Hoosier “Top 50” List

1994

$373.3 Million Net Sales

$25 Million Share Repurchase Program

Acquisition of Kirschner

Reconstructive & Softgoods Products

Performance Knee

Casting Facility in New Jersey

Mfg. Plant in Spain

1995

27% Increase in

International Sales

ArCom Argon Packaged,

Compression Molded

Polyethylene

1996

Mallory-Head Modular Calcar

Revision Series Introduced

Provides Customized

Fixation Alternatives

Launch of EBI DynaFix

External Fixation System

$535.2 Million Net Sales

1996

60,000 Sq. Ft. Addition to Lorenz Surgical

Manufacturing

R&D

1997

Introduction of Indiana Tome

Carpal Tunnel Release System

$580.3 Million Net Sales

2,500 Team Members

26 Facilities totaling 1,071,000

Sq. Ft.

EBI Launched SpineLink

Fixation System

1998

Biomet Merck JV

European Launch of TRAC

Mobile Bearing Knee

$651.4 Million Net Sales

2,750 Team Members

Ascent Total Knee System

Launched

Omega 21 Spinal Fixation &

SpineLink Anterior Cervical

Systems Introduced

1999

Alliance with Selective Genetics to

Develop Gene Therapy Products

$757.4 Million Net Sales

Introduction of Mimix Bone

Substitute Material

Biomet Entered Worldwide Dental

Reconstructive Implant Market

with Acquisition of 3i

2000

M2a Metal-On-Metal Hip

Articulation System

$920.6 Million Net Sales

Stock Split: 3 for 2

Biolectron Acquisition

Added Non-Invasive

Electrical Stimulation

4,000 Team Members

2001

Approximately 100 New Products

& Line Extensions

$1 Billion Net Sales

Stock Split: 3 for 2

Over 270 Million Shares

4,600 Team Members

1,500+ Sales

Representatives

2002

Approximately 80 New Products

$1.2 Billion Net Sales

More than 50 Facilities

(18 Manufacturing)

4,900 Team Members

1,850 Sales Representatives

Share Repurchase Program Initiated

2003

Approximately 85 New Products

Reintroduction of Constrained Liners

Microplasty Minimally-Invasive Instrumentation

$1.4 Billion Net Sales

Expansion of Share Repurchase Program

50% Dividend Increase to $0.15

5,000+ Team Members

2,000+ Sales Representatives

2004

$1.6 Billion Net Sales

Expansion of Share Repurchase Program

33% Dividend Increase to $0.20

Q4 Introduction of Vanguard Complete Knee System

ReCap Femoral Resurfacing

5,300+ Team Members

2,200+ Sales Representatives

2005

$1.9 Billion Net Sales

Rollout of Vanguard Knee

Domestic Introduction of Oxford Partial Knee

25% Dividend Increase to $0.25

Expansion of Share Repurchase Program

500+ New Products Introduced Over the Past 6 Years

6,000+ Team Members

2,400+ Sales Representatives

2006

$2.0 Billion Net Sales

Co-Founder, President/CEO Dane A. Miller, Ph.D. Announces Retirement

Launch of C2a-Taper Acetabular System

Introduction of Vanguard SSK (Super Stabilized Knee) Revision System

20% Dividend Increase to $0.30

600+ New Products Introduced Over the Past 7 Years

6,300 Team Members

2,600 Sales Representatives

2007

$2.1 Billion Net Sales

Company Signs Definitive Merger Agreement With Private Equity Consortium

Jeffrey R. Binder Named President/CEO

Launch of E-Poly (Vitamin E Stabilized Highly Crosslinked Polyethylene)

Introduction of NanoTite Dental Implant

700+ New Products Introduced Overthe Past 8 Years

6,500 Team Members

2,700+ Sales Representatives

2008

$2.4 Billion Net Sales

Completion of the Merger with LVB Acquisition Merger Sub, Inc.

Launch of the Taperloc and the Balance Microplasty Stems

25th Anniversary of Taperloc Hip Stem is Celebrated

Launch of One Patient, our U.S. Advocacy Initiative

Biomet products are used to help one surgeon treat one patient, 1 million times per year

www.onepatient.us

~800 New Products Introduced Over the Past 9 Years

7,200+ Team Members

3,000+ Sales Representatives

2009 $2.5 Billion Net Sales

12% Adjusted EBITDA Growth

12% Constant Currency Growth for Global Orthopedic Reconstructive Device Sales

Strong Market Acceptance of New Technologies, Including:

E1 Antioxidant Infused Bearing Technology

Regenerex Porous Titanium Construct components

Signature Personalized Patient Care pre-operative planning software program, including patient-specific alignment guides

7,200+ Team Members

3,000+ Sales Representatives

~900 New Products Introduced Over the Past 10 Years

2010

$2.7 Billion Net Sales

8% Adjusted EBITDA Growth

10% CC Growth for Global Orthopedic Reconstructive Device Sales

Acquired Assets of Cartilix – Cartilage Repair Technology

Dane A. Miller, Ph.D., Co-Founder, Former CEO, and Current Board Member Named 2009 Phoenix Lifetime Achievement Award Winner

Donated $3.1 Million in Medical Devices for the Haitian Relief Effort

Q1 Introduction of Comprehensive Reverse Shoulder

Introduced Cobalt MV (Medium Viscosity) Bone Cement for Total Joint Reconstruction

~ 7,500 Team Members

3,000+ Sales Representatives

900+ New Products Introduced Over the Past 11 Years

2011

$2.7 Billion Net Sales

Receive FDA Clearance for Active Articulation E1 Dual Mobility Hip System

Acquisition of Substantially all of the Assets of Cytosol Laboratories, Inc.

Biomet 3i collaborates with Renishaw PLC Providing the Latest Digital Dentistry Solutions to Laboratories, Dental Implant Professionals and Patients

Biomet Sports Medicine’s JuggerKnot Soft Anchor Receives 2011 Medical Design Excellence Award

~ 7,500 Team Members

3,000+ Sales Representatives

900+ New Products Introduced Over the Past 12 Years

2012

$2.8 Billion Net Sales

Company Announces Offer to Acquire DePuy Trauma Business

FDA Clearance for Two New Products:

E1 Humeral Bearing for the Comprehensive Reverse Shoulder System

The Comprehensive Segmental Revision System

Company Celebrates 35 Years of Clinical Experience with the Oxford Partial Knee System

8,000 Team Members

3,000+ Sales Representatives

Global Footprint With Operations in 50+ Location